Clinical trial

Imaging Biomarker in Cancer Drug Induced ILD

NCT03294746

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-01-01

PhaseNA

Study timeline

Study start (estimated)2018-01-01Date precision: month

Registry last updated2017-09-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Drug Induced Interstitial Lung Disease (DIILD) Cancer Patientsunresolved

Interventions

Clinical evaluationsOTHER

Thoracic CTOTHER

Sponsors & collaborators

European Organisation for Research and Treatment of Cancer - EORTClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03294746 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.